Estrogen Blockers Market, By Product Type, By Application, By Distribution Channel, By Geography

PUBLISHED: November 1, 2023

PAGES: 150 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The global estrogen blockers market size was valued at US$ 15.02 billion in 2023 and is expected to reach US$ 23.34 billion by 2030, growing at a CAGR of 6.5% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 15.02 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.50%	2030 Value Projection:	US$ 23.34 Bn

Figure 1. Global Estrogen Blockers Market Share (%), By Region, 2023

Estrogen blockers are medicines that are used by FTM (female to male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of estrogen blockers available, and some are more effective than others.

Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.

Market Dynamics

Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.

For instance, on June 28, 2023, according to a report published by the World Health Organization, reported that polycystic ovary syndrome (PCOS) is a significant public health problem and considered as one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age every year, and up to 70% of cases are undiagnosed.

On the other hand, like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term use of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.

Key features of the study:

This report provides in-depth analysis of the global estrogen blockers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global estrogen blockers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc, Olema Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Allorion Therapeutics Inc, Carrick Therapeutics Limited, Criterium, Inc. and Hoffmann-La Roche
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market

Detailed Segmentation:

Global Estrogen Blockers Market, By Product Type:
- Selective Estrogen Receptor Modulators (SERMs)
- Aromatase Inhibitors
- Estrogen Receptor Downregulators (ERDs)
- Others
Global Estrogen Blockers Market, By Application:
- Breast Cancer Treatment
- Hormone Replacement Therapy (HRT)
- Infertility Treatment
- Post-Menopausal Osteoporosis
- Others
Global Estrogen Blockers Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Estrogen Blockers Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Estrogen Blockers Market, By Company:
- Pfizer Inc.
- Novartis AG
- AstraZeneca PLC
- Eli Lilly and Company
- Merck & Co., Inc.
- Bristol Myers Squibb Company
- Sanofi S.A.
- AbbVie Inc.
- GlaxoSmithKline plc
- Olema Pharmaceuticals, Inc.
- Scorpion Therapeutics, Inc.
- Allorion Therapeutics Inc
- Carrick Therapeutics Limited
- Criterium, Inc.
- F.Hoffmann-La Roche

Product Code: CMI5995

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Estrogen Blockers, By Product Type
- Market Estrogen Blockers, By Application
- Market Estrogen Blockers, By Distribution Channel
- Market Estrogen Blockers, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Hormone-related Disorders
- Restraints
Side Effects and Safety Concerns
- Opportunities
Expansion of Indications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Estrogen Blockers Market , By Product Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Selective Estrogen Receptor Modulators (SERMs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Aromatase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Estrogen Receptor Downregulators (ERDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Estrogen Blockers Market , By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Breast Cancer Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Hormone Replacement Therapy (HRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Infertility Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Post-Menopausal Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Estrogen Blockers Market , By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Estrogen Blockers Market , By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
AstraZeneca PLC
Eli Lilly and Company
Merck & Co., Inc.
Bristol Myers Squibb Company
Sanofi S.A.
AbbVie Inc.
GlaxoSmithKline plc
Olema Pharmaceuticals, Inc.
Scorpion Therapeutics, Inc.
Allorion Therapeutics Inc
Carrick Therapeutics Limited
Criterium, Inc.
F.Hoffmann-La Roche
Analyst Views